Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

  • Read more about Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

  • Read more about A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

  • Read more about MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumor

  • Read more about Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumor

Corticosteroids in Severe COVID-19(ASAP-C Study)

  • Read more about Corticosteroids in Severe COVID-19(ASAP-C Study)

Expanded Access to Zofin for Patients With COVID-19

  • Read more about Expanded Access to Zofin for Patients With COVID-19

Hyperpolarized 129Xe MRI of Survivors of COVID-19

  • Read more about Hyperpolarized 129Xe MRI of Survivors of COVID-19

COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes

  • Read more about COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes

Symptom-Based Markers for COVID-19 Transmission

  • Read more about Symptom-Based Markers for COVID-19 Transmission

Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

  • Read more about Evaluation of Safety and Tolerability of COR-101 in Hospitalized Patients With Moderate to Severe COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 212
  • Page 213
  • Page 214
  • Page 215
  • Current page 216
  • Page 217
  • Page 218
  • Page 219
  • Page 220
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA